Brief: Jcr Pharmaceuticals Co Ltd Jcr Announces Achievement Of Milestone Using J-Brain Cargo Technology For Neurodegenerative Disease In Research Collaboration With Alexion
19/03/2024 07:02
JCR Pharmaceuticals Co Ltd 4552.T :
* JCR PHARMACEUTICALS CO LTD: JCR ANNOUNCES ACHIEVEMENT OF
MILESTONE USING J-BRAIN CARGO TECHNOLOGY FOR NEURODEGENERATIVE
DISEASE IN RESEARCH COLLABORATION WITH ALEXION
Source text for Eikon: ID:nTSos87c7d
Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results